tiprankstipranks
Lifecore Biomedical (DE:LDE)
FRANKFURT:LDE
Germany Market
LDE
Lifecore Biomedical
RESEARCH TOOLSreports

Lifecore Biomedical (LDE) Ratios

1 Followers

Lifecore Biomedical Ratios

DE:LDE's free cash flow for Q4 2026 was $0.35. For the 2026 fiscal year, DE:LDE's free cash flow was decreased by $ and operating cash flow was $0.05. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25May 25May 24Aug 23
Liquidity Ratios
Current Ratio
 3.87 3.49 2.84 2.08 2.39
Quick Ratio
 2.69 2.26 1.77 1.06 1.35
Cash Ratio
 0.80 0.74 0.27 0.22 0.49
Solvency Ratio
 -0.13 -0.09 -0.13 0.08 -0.34
Operating Cash Flow Ratio
 0.10 0.53 >-0.01 <0.01 -0.44
Short-Term Operating Cash Flow Coverage
 2.15 16.26 -0.06 0.27 -30.07
Net Current Asset Value
$ -129.72M$ -164.09M$ -152.33M$ -161.61M$ -163.90M
Leverage Ratios
Debt-to-Assets Ratio
 0.68 0.61 0.55 0.53 0.44
Debt-to-Equity Ratio
 9.64 -10.04 97.92 11.81 -26.63
Debt-to-Capital Ratio
 0.91 1.11 0.99 0.92 1.04
Long-Term Debt-to-Capital Ratio
 0.91 1.12 0.99 0.92 1.04
Financial Leverage Ratio
 14.26 -16.35 179.15 22.44 -59.94
Debt Service Coverage Ratio
 -0.15 -5.32 -0.35 1.86 -1.84
Interest Coverage Ratio
 -0.09 0.57 -0.79 -0.49 -1.23
Debt to Market Cap
 0.96 0.50 0.56 0.73 0.43
Interest Debt Per Share
 4.90 4.22 4.38 4.98 4.35
Net Debt to EBITDA
 -33.30 15.18 -13.91 3.51 -2.82
Profitability Margins
Gross Profit Margin
29.68%31.37%31.27%32.63%27.10%
EBIT Margin
-10.98%-0.97%-13.07%21.52%-44.88%
EBITDA Margin
-3.38%6.37%-6.84%27.76%-32.12%
Operating Profit Margin
-2.12%-0.97%-13.38%-6.90%-21.11%
Pretax Profit Margin
-30.06%-23.34%-30.01%7.42%-61.90%
Net Profit Margin
-30.40%-23.78%-30.04%9.37%-96.41%
Continuous Operations Profit Margin
-30.40%-23.78%-30.04%7.28%-62.20%
Net Income Per EBT
101.14%101.91%100.11%126.27%155.74%
EBT Per EBIT
1415.01%2404.36%224.26%-107.58%293.30%
Return on Assets (ROA)
-16.25%-13.26%-16.18%4.73%-39.27%
Return on Equity (ROE)
-376.95%216.80%-2897.98%106.17%2353.74%
Return on Capital Employed (ROCE)
-1.25%-0.60%-8.24%-4.11%-10.17%
Return on Invested Capital (ROIC)
-1.25%-0.60%-8.10%-3.94%-10.09%
Return on Tangible Assets
-17.29%-14.10%-17.50%5.09%-42.28%
Earnings Yield
-23.02%-11.32%-16.55%7.01%-41.86%
Efficiency Ratios
Receivables Turnover
 4.03 3.83 2.95 4.12 3.56
Payables Turnover
 11.45 15.22 10.77 5.29 3.41
Inventory Turnover
 3.39 3.06 2.74 2.16 1.84
Fixed Asset Turnover
 0.99 1.02 1.00 0.86 0.74
Asset Turnover
 0.53 0.56 0.54 0.51 0.41
Working Capital Turnover Ratio
 1.98 2.27 2.64 2.65 -38.77
Cash Conversion Cycle
 166.58 190.83 222.88 188.53 193.46
Days of Sales Outstanding
 90.64 95.34 123.68 88.65 102.58
Days of Inventory Outstanding
 107.83 119.48 133.07 168.87 198.01
Days of Payables Outstanding
 31.89 23.99 33.88 68.99 107.13
Operating Cycle
 198.47 214.82 256.76 257.53 300.59
Cash Flow Ratios
Operating Cash Flow Per Share
 0.06 0.38 >-0.01 <0.01 -0.58
Free Cash Flow Per Share
 -0.05 0.19 -0.39 -0.60 -1.30
CapEx Per Share
 0.10 0.19 0.39 0.60 0.72
Free Cash Flow to Operating Cash Flow
 -0.86 0.50 66.12 -70.58 2.23
Dividend Paid and CapEx Coverage Ratio
 0.54 1.98 -0.02 0.01 -0.81
Capital Expenditure Coverage Ratio
 0.54 1.98 -0.02 0.01 -0.81
Operating Cash Flow Coverage Ratio
 0.01 0.09 >-0.01 <0.01 -0.15
Operating Cash Flow to Sales Ratio
 0.02 0.10 >-0.01 <0.01 -0.17
Free Cash Flow Yield
-1.11%2.29%-5.82%-10.59%-16.36%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -3.92 -8.89 -5.29 14.26 -2.39
Price-to-Sales (P/S) Ratio
 1.32 2.10 1.82 1.34 2.30
Price-to-Book (P/B) Ratio
 10.06 -19.16 175.14 15.14 -56.23
Price-to-Free Cash Flow (P/FCF) Ratio
 -89.96 43.67 -17.18 -9.44 -6.11
Price-to-Operating Cash Flow Ratio
 77.71 21.65 -1.14K 666.40 -13.64
Price-to-Earnings Growth (PEG) Ratio
 0.31 0.32 0.01 -0.13 0.15
Price-to-Fair Value
 10.06 -19.16 175.14 15.14 -56.23
Enterprise Value Multiple
 -72.36 48.19 -40.46 8.32 -9.99
Enterprise Value
 299.49M 397.22M 356.54M 296.38M 331.40M
EV to EBITDA
 -72.36 48.19 -40.46 8.32 -9.99
EV to Sales
 2.44 3.07 2.77 2.31 3.21
EV to Free Cash Flow
 -166.66 63.76 -26.18 -16.34 -8.51
EV to Operating Cash Flow
 143.71 31.61 -1.73K 1.15K -19.00
Tangible Book Value Per Share
 0.06 -0.84 -0.48 -0.22 -0.74
Shareholders’ Equity Per Share
 0.43 -0.43 0.04 0.37 -0.14
Tax and Other Ratios
Effective Tax Rate
 -0.01 -0.02 >-0.01 0.02 >-0.01
Revenue Per Share
 3.26 3.89 3.70 4.21 3.45
Net Income Per Share
 -0.99 -0.93 -1.11 0.39 -3.32
Tax Burden
 1.01 1.02 1.00 1.26 1.56
Interest Burden
 2.74 24.04 2.30 0.34 1.38
Research & Development to Revenue
 0.05 0.07 0.06 0.07 0.08
SG&A to Revenue
 0.27 0.26 0.34 0.00 0.00
Stock-Based Compensation to Revenue
 0.07 0.05 0.08 0.05 0.03
Income Quality
 -0.06 -0.40 <0.01 0.02 0.18
Currency in USD